Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China
· Delayed Price · Currency is CNY 11.78
+0.05 (0.43%)
Mar 10, 2026, 3:00 PM CST
SHA:603439 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 265.69 | 476.07 | 571.37 | 570.88 | 544.22 | 450.05 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 130 | Upgrade
|
| Trading Asset Securities | 59.7 | 22.95 | 51.5 | 59.91 | 98 | - | Upgrade
|
| Cash & Short-Term Investments | 325.4 | 499.02 | 622.87 | 630.79 | 642.22 | 580.05 | Upgrade
|
| Cash Growth | -45.14% | -19.89% | -1.26% | -1.78% | 10.72% | 142.08% | Upgrade
|
| Accounts Receivable | 700.57 | 932.12 | 682.86 | 432.82 | 312.8 | 288.77 | Upgrade
|
| Other Receivables | 4.67 | 2.53 | 3.32 | 2.18 | 51.41 | 0.86 | Upgrade
|
| Receivables | 705.25 | 934.65 | 686.18 | 435.01 | 364.21 | 289.63 | Upgrade
|
| Inventory | 324.73 | 320.72 | 175.72 | 98.08 | 88.57 | 47.51 | Upgrade
|
| Other Current Assets | 53.85 | 43.59 | 8.69 | 8.18 | 4.55 | 2.83 | Upgrade
|
| Total Current Assets | 1,409 | 1,798 | 1,493 | 1,172 | 1,100 | 920.01 | Upgrade
|
| Property, Plant & Equipment | 540.3 | 585.15 | 615.13 | 237.4 | 157.91 | 154.36 | Upgrade
|
| Long-Term Investments | 89.57 | 22.55 | 10.08 | 129.77 | 119.13 | 167.82 | Upgrade
|
| Goodwill | 554.61 | 554.61 | 554.61 | 161.66 | - | - | Upgrade
|
| Other Intangible Assets | 198.95 | 216.13 | 235.23 | 107.3 | 20.38 | 11.84 | Upgrade
|
| Long-Term Deferred Tax Assets | 14.52 | 15.13 | 11.08 | 6.89 | 5.12 | 4.76 | Upgrade
|
| Long-Term Deferred Charges | 0.64 | 0.56 | 0.86 | 1.54 | 2.9 | - | Upgrade
|
| Total Assets | 2,848 | 3,192 | 2,920 | 1,817 | 1,405 | 1,259 | Upgrade
|
| Accounts Payable | 135.35 | 342.73 | 247.98 | 165.26 | 98.84 | 35.38 | Upgrade
|
| Accrued Expenses | 4.42 | 67.33 | 39.48 | 31.33 | 16.59 | 12.58 | Upgrade
|
| Short-Term Debt | 575.48 | 351.52 | 255.32 | 205 | 200 | 200 | Upgrade
|
| Current Portion of Long-Term Debt | 52.71 | 45.15 | 45.22 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 0.5 | 0.15 | 0.5 | - | - | Upgrade
|
| Current Income Taxes Payable | 20.23 | 13.84 | 12.77 | 10.91 | 9.4 | 7.61 | Upgrade
|
| Current Unearned Revenue | 7.74 | 7.79 | 8.17 | 78.96 | 5.83 | 5.89 | Upgrade
|
| Other Current Liabilities | 177.42 | 405.59 | 229.92 | 56.72 | 29.76 | 2.45 | Upgrade
|
| Total Current Liabilities | 973.37 | 1,234 | 839.01 | 548.68 | 360.42 | 263.91 | Upgrade
|
| Long-Term Debt | 179.4 | 209.3 | 254.15 | - | - | - | Upgrade
|
| Long-Term Leases | 0.05 | 0.21 | 0.17 | 0.17 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 39.91 | 42.97 | 35.97 | 12.5 | 12.5 | 13 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 22.87 | 25.5 | 28.88 | 6.94 | - | - | Upgrade
|
| Other Long-Term Liabilities | 84.43 | 85.04 | 52.92 | 10.1 | - | - | Upgrade
|
| Total Liabilities | 1,300 | 1,597 | 1,211 | 578.4 | 372.93 | 276.91 | Upgrade
|
| Common Stock | 409.8 | 409.8 | 409.86 | 410.86 | 410.86 | 407.32 | Upgrade
|
| Additional Paid-In Capital | 159.23 | 149.04 | 225.12 | 229.69 | 223.39 | 201.27 | Upgrade
|
| Retained Earnings | 1,012 | 1,069 | 876.75 | 625.04 | 423.75 | 373.3 | Upgrade
|
| Treasury Stock | -100.64 | -100.64 | -41.43 | -26.55 | -26.55 | - | Upgrade
|
| Total Common Equity | 1,481 | 1,527 | 1,470 | 1,239 | 1,031 | 981.89 | Upgrade
|
| Minority Interest | 67.47 | 67.29 | 239.04 | -0.82 | 0.61 | -0.02 | Upgrade
|
| Shareholders' Equity | 1,548 | 1,595 | 1,709 | 1,238 | 1,032 | 981.88 | Upgrade
|
| Total Liabilities & Equity | 2,848 | 3,192 | 2,920 | 1,817 | 1,405 | 1,259 | Upgrade
|
| Total Debt | 807.65 | 606.68 | 555.02 | 205.67 | 200 | 200 | Upgrade
|
| Net Cash (Debt) | -482.25 | -107.67 | 67.86 | 425.12 | 442.22 | 380.05 | Upgrade
|
| Net Cash Growth | - | - | -84.04% | -3.87% | 16.36% | 58.61% | Upgrade
|
| Net Cash Per Share | -1.20 | -0.26 | 0.16 | 1.03 | 1.07 | 0.97 | Upgrade
|
| Filing Date Shares Outstanding | 405.61 | 405.61 | 408.25 | 410.86 | 410.86 | 407.32 | Upgrade
|
| Total Common Shares Outstanding | 405.61 | 405.61 | 408.25 | 410.86 | 410.86 | 407.32 | Upgrade
|
| Working Capital | 435.86 | 563.53 | 654.46 | 623.38 | 739.12 | 656.1 | Upgrade
|
| Book Value Per Share | 3.65 | 3.77 | 3.60 | 3.02 | 2.51 | 2.41 | Upgrade
|
| Tangible Book Value | 727.13 | 756.61 | 680.48 | 970.09 | 1,011 | 970.05 | Upgrade
|
| Tangible Book Value Per Share | 1.79 | 1.87 | 1.67 | 2.36 | 2.46 | 2.38 | Upgrade
|
| Buildings | - | 543.28 | 549.09 | 181.14 | 152.85 | 152.85 | Upgrade
|
| Machinery | - | 351.45 | 344.91 | 103.27 | 58.44 | 48.76 | Upgrade
|
| Construction In Progress | - | - | 0.04 | 48.59 | 4.17 | 0.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.